The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation

Membranous nephropathy (MN) is estimated to cause end-stage renal disease in ∼ 5% of patients, in whom renal transplantation is the therapy of choice. Among patients receiving a transplant for MN, the disease will recur in the graft in 30–50%; among these, graft loss will occur in 50% within 10 year...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Kidney J
Main Authors: Xipell, Marc, Rodas, Lida M, Villarreal, Jesús, Molina, Alicia, Reinoso-Moreno, Johanna, Blasco, Miquel, Poch, Esteban, Diekmann, Fritz, Campistol, Jose M, Quintana, Luis F
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Transplantation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007417/
https://ncbi.nlm.nih.gov/pubmed/29988247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx128
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki